SCM
HAE icon

Stevens Capital Management’s Haemonetics HAE Stock Holding History

Stevens Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,404
Closed -$391K – 183
2019
Q4 		$391K Buy
+3,404
New +$412K 0.04% 394
2019
Q2 		– Sell
-27,030
Closed -$2.37M – 723
2019
Q1 		$2.37M Buy
27,030
+12,971
+92% +$1.18M 0.1% 238
2018
Q4 		$1.41M Buy
+14,059
New +$1.48M 0.07% 319
2018
Q3 		– Sell
-34,594
Closed -$3.1M – 822
2018
Q2 		$3.1M Buy
+34,594
New +$2.92M 0.11% 215
2018
Q1 		– Sell
-5,088
Closed -$296K – 840
2017
Q4 		$296K Sell
5,088
-5,392
-51% -$284K 0.01% 665
2017
Q3 		$470K Sell
10,480
-17,264
-62% -$717K 0.02% 570
2017
Q2 		$1.1M Buy
27,744
+18,914
+214% +$777K 0.04% 405
2017
Q1 		$358K Buy
8,830
+3,375
+62% +$132K 0.01% 657
2016
Q4 		$219K Buy
+5,455
New +$206K 0.01% 761
2016
Q3 		– Sell
-7,631
Closed -$221K – 995
2016
Q2 		$221K Sell
7,631
-13,530
-64% -$409K 0.01% 750
2016
Q1 		$740K Buy
21,161
+11,691
+123% +$378K 0.03% 492
2015
Q4 		$305K Sell
9,470
-13,517
-59% -$438K 0.01% 687
2015
Q3 		$743K Buy
22,987
+348
+2% +$13.1K 0.03% 424
2015
Q2 		$936K Buy
22,639
+15,886
+235% +$670K 0.03% 443
2015
Q1 		$303K Buy
+6,753
New +$282K 0.01% 744
2014
Q2 		– Sell
-8,457
Closed -$276K – 1149
2014
Q1 		$276K Buy
+8,457
New +$323K 0.01% 818
2013
Q4 		– Sell
-13,869
Closed -$553K – 1094
2013
Q3 		$553K Buy
+13,869
New +$582K 0.02% 617

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Stevens Capital Management's HAE Position: Q1 2020 in Review

Stevens Capital Management sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 3,404 shares — an estimated $391K sold.

Stevens Capital Management first reported a position in HAE in Q3 2013 and held it in 17 quarters. The position peaked at $3.1M in Q2 2018. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • Stevens Capital Management reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 3,404 Haemonetics shares in Q1 2020, an estimated $391K.
  • Stevens Capital Management first reported a position in Haemonetics in Q3 2013 and held it in 17 quarters.
  • Stevens Capital Management's Haemonetics position peaked at $3.1M in Q2 2018.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.